Dylan Scott
Senior Correspondent
Latest articles by Dylan Scott
Too many Americans find it difficult to get mental health care treatment.
Is it time to celebrate the economy’s “soft landing” yet?
What to make of the uptick of Covid-19 this summer — and what to expect this winter.
FDA approval for Opill is historic. But how much will it cost?
The new treatment approved by the FDA is a big deal. Can the US health system handle it?
The myths and questions doctors are hearing from patients about Ozempic.
The doctor shortage is already here, but there’s a way to fix it.
If the government can’t legally constrain prescription drug prices, what can it do?
How the legislation to avert an economic crisis would affect student loans, food aid, the IRS, and more.
Most insurers don’t cover weight loss drugs. But can they afford not to?